Wegovy approved in China

Order byBest matchMost fresh

People lost more weight on Zepbound than Wegovy

Here’s how much extra weight is lost with Zepbound over Wegovy

A study of two blockbuster weight-loss drugs showed that users of Eli Lilly’s Zepbound lost just over 2 inches more off their waists compared with Novo Nordisk’s rival Wegovy. At 72 weeks, participants using Zepbound saw an average weight-loss reduction of 20.

· 1d · on MSN

· 1d

Zepbound Outperforms Wegovy in Head-to-Head Weight Loss Study

· 1d

Eli Lilly Says Trial Patients Lost More Weight on Zepbound Than Rival’s Wegovy

Eli Lilly's Zepbound outperforms Novo Nordisk's Wegovy for weight loss in trial

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day.

· 1d

· 23h

First head-to-head trial found Zepbound beats Wegovy for weight loss

· 1d

New study compares Wegovy and Zepbound for the first time

How copycats of Wegovy, Zepbound created a billion-dollar market

Novo Nordisk cut 2025 sales forecast citing competition from compounded versions of its Wegovy weight-loss drug. Invezz takes a look at how compounding became a multibillion dollar industry.

6don MSN

Novo Nordisk hopes to see US Wegovy sales recover soon

Drugmaker Novo Nordisk expects Wegovy weight-loss drug sales in the United States to start to recover once a ban on compound copycats is enforced this month, its CEO said on Wednesday after the company cut its 2025 forecasts.

NJBIZ7d

Novo Nordisk seeks FDA approval for Wegovy weight loss pill

Novo Nordisk’s oral Wegovy pill for chronic weight loss is under FDA review. If approved, it would be the first oral GLP-1 for obesity.

Trending on Bing

People lost more weight on Zepbound than Wegovy